Erick Lucera

Insider Reports History

Location
North Andover, MA
Signature
/s/ Erick Lucera
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erick Lucera:

Company Role Class Num Shares Value Price $ Report Date Ownership
Dyne Therapeutics, Inc. Chief Financial Officer Common Stock 66,100 $801,132 $12.12 31 Mar 2025 Direct
Editas Medicine, Inc. EVP, CHIEF FINANCIAL OFFICER Common Stock 112,720 $192,841 $1.71 04 Mar 2025 Direct
Dyne Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 214,500 31 Mar 2025 Direct
SAB Biotherapeutics, Inc. Director Stock option (right to buy) 150,000 16 Dec 2025 Direct
Bone Biologics Corp Director Non-Employee Stock Option 85,763 18 Sep 2023 Direct
Editas Medicine, Inc. EVP, CHIEF FINANCIAL OFFICER Stock Option (right to buy) 70,000 08 Mar 2025 Direct
Beyond Air, Inc. Director Stock Options (Right to buy) 3,750 04 Nov 2025 Direct
AVEO PHARMACEUTICALS, INC. Chief Financial Officer Stock Option (Right to Buy) 0 19 Jan 2023 Direct

Insider Reports Filed by Erick Lucera

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SABS SAB Biotherapeutics, Inc. 16 Dec 2025 1 $0 4 Director 18 Dec 2025, 16:50
XAIR Beyond Air, Inc. 04 Nov 2025 16 $0 4 Director 06 Nov 2025, 21:51
DYN Dyne Therapeutics, Inc. 31 Mar 2025 2 $0 4 Chief Financial Officer 01 Apr 2025, 16:33
DYN Dyne Therapeutics, Inc. 31 Mar 2025 0 $0 3 Chief Financial Officer 01 Apr 2025, 16:31
XAIR Beyond Air, Inc. 26 Mar 2025 1 $0 4 Director 28 Mar 2025, 17:12
EDIT Editas Medicine, Inc. 08 Mar 2025 2 $0 4 EVP, CHIEF FINANCIAL OFFICER 27 Mar 2025, 16:41
EDIT Editas Medicine, Inc. 04 Mar 2025 1 -$7,030 4 EVP, CHIEF FINANCIAL OFFICER 05 Mar 2025, 16:44
XAIR Beyond Air, Inc. 22 Nov 2024 14 $0 4 Director 26 Nov 2024, 21:54
XAIR Beyond Air, Inc. 14 Aug 2024 1 +$15,565 4 Director 15 Aug 2024, 17:09
SABS SAB Biotherapeutics, Inc. 15 Jul 2024 1 $0 4 Director 17 Jul 2024, 16:30
EDIT Editas Medicine, Inc. 20 May 2024 1 -$125,404 4 EVP, CHIEF FINANCIAL OFFICER 22 May 2024, 16:30
XAIR Beyond Air, Inc. 20 Mar 2024 1 $0 4 Director 21 Mar 2024, 21:01
EDIT Editas Medicine, Inc. 02 Mar 2024 3 $0 4 EVP, CHIEF FINANCIAL OFFICER 05 Mar 2024, 20:06
BBLG Bone Biologics Corp 18 Sep 2023 1 $0 4 Director 20 Sep 2023, 14:54
EDIT Editas Medicine, Inc. 17 May 2023 2 $0 4 EVP, CHIEF FINANCIAL OFFICER 18 May 2023, 17:20
EDIT Editas Medicine, Inc. 17 May 2023 0 $0 3 EVP, CHIEF FINANCIAL OFFICER 18 May 2023, 17:18
SABS SAB Biotherapeutics, Inc. 03 Apr 2023 1 $0 4 Director 05 Apr 2023, 17:01
SABS SAB Biotherapeutics, Inc. 03 Apr 2023 0 $0 3 Director 05 Apr 2023, 17:00
XAIR Beyond Air, Inc. 29 Mar 2023 1 $0 4 Director 31 Mar 2023, 16:15
XAIR Beyond Air, Inc. 16 Mar 2023 1 +$13,634 4 Director 20 Mar 2023, 16:10
AVEO AVEO PHARMACEUTICALS, INC. 19 Jan 2023 3 $0 4 Chief Financial Officer 19 Jan 2023, 16:11
BBLG Bone Biologics Corp 23 Aug 2022 1 $0 4 Director 08 Mar 2023, 05:20
XAIR Beyond Air, Inc. 03 Mar 2022 1 $0 4 Director 07 Mar 2022, 07:33
AVEO AVEO PHARMACEUTICALS, INC. 15 Feb 2022 1 $0 4 Chief Financial Officer 17 Feb 2022, 16:00
BBLG Bone Biologics Corp 26 Oct 2021 2 $0 4 Director 28 Feb 2022, 05:02
BBLG Bone Biologics Corp 15 Oct 2021 0 $0 3 Director 21 Oct 2021, 17:20